Verified Supplement Data Primary-sourced

SAMe Supplements Guide (2026): Depression & Joint Evidence, Dose & Stability

By Erin Rose · Updated · Methodology · About Us

SAMe is one of the few supplements with pharmaceutical-grade evidence: randomized trials find it comparable to some prescription antidepressants for depression, and it also has real data for osteoarthritis pain. The catch is dose and quality. Studied doses run high (400–1,600 mg/day, which gets expensive), the molecule is chemically unstable and needs enteric coating and fresh, foil-blistered stock, and it can trigger mania in bipolar disorder or interact with serotonergic drugs — so it's a talk-to-your-doctor supplement, not a casual one. Below: the evidence, dosing, and what to look for on the label.

About our data

Every comparison uses clinical evidence from PubMed systematic reviews, product label data from the NIH Dietary Supplement Label Database, and third-party certifications (USP, NSF). Products are ranked by cost per clinically-effective dose. See our methodology and editorial standards.